New insider Parison Amy claimed ownership of 17,952 shares (SEC Form 3)
$EDIT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/28/2025 |
3. Issuer Name and Ticker or Trading Symbol
Editas Medicine, Inc. [ EDIT ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 17,952(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (right to buy) | (2) | 09/08/2032 | Common Stock | 26,850 | $15.83 | D | |
| Stock Option (right to buy) | (3) | 03/01/2033 | Common Stock | 6,091 | $8.72 | D | |
| Stock Option (right to buy) | (4) | 03/01/2034 | Common Stock | 17,220 | $9.92 | D | |
| Stock Option (right to buy) | (5) | 03/07/2035 | Common Stock | 42,880 | $1.72 | D | |
| Stock Option (right to buy) | (6) | 03/07/2035 | Common Stock | 145,548 | $1.72 | D | |
| Explanation of Responses: |
| 1. Consists of (i) 4,330 shares of Common Stock and (ii) 13,622 shares of Common Stock issuable under restricted stock units ("RSUs") awarded to the Reporting Person, for no consideration, that vest periodically subject to the Reporting Person's continued service. Each RSU represents the right to receive one share of Common Stock upon vesting. |
| 2. This option was granted on September 9, 2022 and is scheduled to vest over four years, with 25% of the shares having vested on August 1, 2023, and the remaining 75% of the shares vesting in equal monthly installments thereafter through August 1, 2026. |
| 3. This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027. |
| 4. This option was granted on March 2, 2024 and is scheduled vest over four years in equal monthly installments beginning on April 2, 2024 through March 2, 2028. |
| 5. This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026. |
| 6. This option was granted on March 8, 2025 and is scheduled to vest over four years, in equal monthly installments beginning on April 8, 2025 through March 8, 2029. |
| Remarks: |
| /s/ Amy Parison | 04/08/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||